Cargando…
Risk-Return Analysis of the Biopharmaceutical Industry as Compared to Other Industries
Background: Profits in the biopharmaceutical industry have been scrutinized in social debate. However, drawing conclusions based on industry profitability only is inappropriate as such an analysis does not account for risks faced by investors. This study aims to measure risks and returns in the biop...
Autores principales: | Popa, Cedric, Holvoet, Karel, Van Montfort, Tessa, Groeneveld, Floris, Simoens, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174211/ https://www.ncbi.nlm.nih.gov/pubmed/30327601 http://dx.doi.org/10.3389/fphar.2018.01108 |
Ejemplares similares
-
The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial Landscape
por: Moorkens, Evelien, et al.
Publicado: (2017) -
Current situation and future development of the biopharmaceutical industry in China: A mixed-method study
por: Yang, Ruomeng, et al.
Publicado: (2022) -
Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs
por: Pauwels, Kim, et al.
Publicado: (2016) -
University–industry collaboration and firm innovation: an empirical study of the biopharmaceutical industry
por: Tian, Mingyu, et al.
Publicado: (2021) -
Considerations for applying bioethics norms to a biopharmaceutical industry setting
por: Van Campen, Luann E., et al.
Publicado: (2021)